16-89645945-C-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001083314.4(CHMP1A):āc.692G>Cā(p.Arg231Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000324 in 1,611,554 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Consequence
NM_001083314.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP1A | NM_002768.5 | c.*121G>C | 3_prime_UTR_variant | 7/7 | ENST00000397901.8 | NP_002759.2 | ||
CHMP1A | NM_001083314.4 | c.692G>C | p.Arg231Pro | missense_variant | 6/6 | NP_001076783.1 | ||
CHMP1A | XM_047434195.1 | c.*121G>C | 3_prime_UTR_variant | 7/7 | XP_047290151.1 | |||
CHMP1A | NR_046418.3 | n.1000G>C | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP1A | ENST00000397901.8 | c.*121G>C | 3_prime_UTR_variant | 7/7 | 1 | NM_002768.5 | ENSP00000380998.3 |
Frequencies
GnomAD3 genomes AF: 0.00182 AC: 277AN: 152228Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000449 AC: 110AN: 245158Hom.: 0 AF XY: 0.000321 AC XY: 43AN XY: 133770
GnomAD4 exome AF: 0.000168 AC: 245AN: 1459208Hom.: 0 Cov.: 31 AF XY: 0.000138 AC XY: 100AN XY: 725906
GnomAD4 genome AF: 0.00182 AC: 277AN: 152346Hom.: 1 Cov.: 33 AF XY: 0.00172 AC XY: 128AN XY: 74500
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
CHMP1A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 20, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at